MARKET

ARKG

ARKG

ARK Genomic Revolution ETF
BATS
29.18
+0.21
+0.72%
After Hours: 29.20 +0.02 +0.07% 18:56 01/02 EST
OPEN
29.23
PREV CLOSE
28.97
HIGH
29.41
LOW
28.74
VOLUME
2.05M
TURNOVER
--
52 WEEK HIGH
34.07
52 WEEK LOW
17.51
TOTAL ASSET
1.16B
YTD YIELD
22.72%
1D
5D
1M
3M
1Y
5Y
1D
Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — Key Trends for 2026
TipRanks · 11h ago
Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks
Benzinga · 12/31/2025 22:06
Cathie Wood invests heavily in gene-editing companies, offloads $30 million worth Tesla stock
Seeking Alpha · 12/29/2025 13:15
Weekly Report: what happened at ARKG last week (1222-1226)?
Weekly Report · 12/29/2025 10:24
Beyond S&P 500: KKR Flags Asia, Biotech, Infrastructure As Next 'High-Grade' Trades For 2026
Benzinga · 12/24/2025 08:12
Cathie Wood Is Doubling Down on Recursion Pharmaceuticals Stock. Should You Buy RXRX Here?
Barchart · 12/24/2025 08:00
Noteworthy ETF Outflows: ARKG, TEM, TWST, GH
NASDAQ · 12/23/2025 16:07
Cathie Wood's weekly recap: boots bets on AI biotech, crypto; pares back consumer names
Seeking Alpha · 12/22/2025 11:30
More
Profile
Fund Name
ARK Genomic Revolution ETF
Inception Date
2014-10-31
Benchmark
NASDAQ Health Care GR EUR
Advisor Company
ARK ETF Trust
Custodian
The Bank of New York Mellon
Manager
Catherine Wood